Speaker illustration

Doctor Karl-Patrik Kresoja

Heart Center of Leipzig, Leipzig (Germany)

Member of:

EAPCI
Heart Failure Association

Open panel discussion.

Event: ESC Congress 2022

Topic: Valvular Heart Disease

Session: HFpEF vs. HFrEF in patients with tricuspid regurgitation: does it matter for TTVr?

Thumbnail

Current evidence for tricuspid repair across HF subtypes.

Event: ESC Congress 2022

Topic: Valvular Heart Disease

Session: HFpEF vs. HFrEF in patients with tricuspid regurgitation: does it matter for TTVr?

Thumbnail

Machine learning to identify patients response to spironolactone treatment in patients with heart failure with preserved ejection fraction

Event: Heart Failure 2022

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: HFpEF: only one disease?

Thumbnail

Effects of sympathetic modulation by renal denervation in patients with heart failure and preserved ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pathophysiology

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Predicting in-hospital major bleeding in pulmonary embolism patients treated with systemic thrombolytic therapy

Event: ESC Congress 2018

Topic: Pulmonary Embolism (PE)

Session: Young Investigator Award Session Thrombosis

Thumbnail

Validation of the VTE-BLEED score for predicting 30-day major bleeding in a real-world cohort of patients with pulmonary embolism

Event: ESC CONGRESS 2017

Topic: Acute pulmonary embolism

Session: After pulmonary embolism: optimising treatment and follow up

Thumbnail

This platform is supported by

logo Novo Nordisk